Multi-bank foreign exchange portal Atriax has signed up global pharmaceutical company Merck & Co. to its advisory board.
Based in New Jersey, USA, Merck researches, develops, manufactures and markets a broad range of human and animal healthcard products. The company’s net income in 2000 was $6.8 billion on a turnover of $40.4 billion.
The addition of Merck to the Atriax advisory board brings the total number of corporate and financial institution board members to twenty-five. As well as guaranteeing liquidity, the board members provide feedback in the development of new products and services for Atriax and assist in the definition of market protocols and the development of standard interfaces.